KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to -$107000.0.

  • CareDx's Other Non Operating Income fell 13780.92% to -$107000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $696000.0, marking a year-over-year decrease of 5146.44%. This contributed to the annual value of $329000.0 for FY2024, which is 7550.26% down from last year.
  • As of Q3 2025, CareDx's Other Non Operating Income stood at -$107000.0, which was down 13780.92% from $72000.0 recorded in Q2 2025.
  • CareDx's 5-year Other Non Operating Income high stood at $2.8 million for Q2 2021, and its period low was -$3.4 million during Q3 2021.
  • Moreover, its 5-year median value for Other Non Operating Income was -$245000.0 (2021), whereas its average is -$187789.5.
  • The largest annual percentage gain for CareDx's Other Non Operating Income in the last 5 years was 118980.39% (2021), contrasted with its biggest fall of 125433.07% (2021).
  • Over the past 5 years, CareDx's Other Non Operating Income (Quarter) stood at -$1.7 million in 2021, then soared by 46.34% to -$924000.0 in 2022, then soared by 266.77% to $1.5 million in 2023, then crashed by 71.71% to $436000.0 in 2024, then tumbled by 124.54% to -$107000.0 in 2025.
  • Its Other Non Operating Income was -$107000.0 in Q3 2025, compared to $72000.0 in Q2 2025 and $295000.0 in Q1 2025.